Daniel Classen, MD, MS
Vanderbilt University Medical Center
Dr. Daniel Claassen is a Neurologist who specializes in the treatment of neurodegenerative disorders characterized by disruptions to cognition, behavior, and movement. He is the Chief of the Behavioral and Cognitive Neurology division at Vanderbilt University Medical center. His research efforts focus on the neurobiology of behavior, where he employs multimodal imaging and cognitive neuroscience methods to understand and develop novel treatments. He leads early and late phase clinical trials that assess symptomatic and disease modifying therapies in MSA, and has successfully lead studies of non-pharmacologic interventions in neurodegenerative disorders. His research is funded by the National Institutes of Health, Department of Defense, and several foundations which include the Griffin Foundation, and CHDI. He is the editor of HD Insights, a publication of the Huntington Study Group (HSG), the scientific director of the Southeast Clinical Neuroscience Society, and an active board member of the MSA Coalition.